DEPODUR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Depodur, and when can generic versions of Depodur launch?
Depodur is a drug marketed by Pacira Pharms Inc and is included in one NDA.
The generic ingredient in DEPODUR is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depodur
A generic version of DEPODUR was approved as morphine sulfate by HOSPIRA on September 30th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEPODUR?
- What are the global sales for DEPODUR?
- What is Average Wholesale Price for DEPODUR?
Summary for DEPODUR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 11 |
Patent Applications: | 5,506 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEPODUR at DailyMed |
![DEPODUR drug patent expirations Drug patent expirations by year for DEPODUR](/p/graph/s/t/DEPODUR-patent-expirations.png)
Recent Clinical Trials for DEPODUR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Columbia University | Phase 4 |
Washington University School of Medicine | N/A |
Wake Forest University | Phase 4 |
US Patents and Regulatory Information for DEPODUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPODUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEPODUR
See the table below for patents covering DEPODUR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 1205588 | ⤷ Sign Up | |
Canada | 2692302 | PROCEDE SERVANT A UTILISER DES LIPIDES NEUTRES AFIN DE MODIFIER LA LIBE ATION IN VIVO DEPUIS DES LIPOSOMES A VESICULES MULTIPLES (METHOD FOR UTILIZING NEUTRAL LIPIDS TO MODIFY IN VIVO RELEASE FROM MULTIVESICULAR LIPOSOMES) | ⤷ Sign Up |
Portugal | 86805 | PROCESSO PARA A PREPARACAO DE COMPOSICOES FARMACEUTICAS CONTENDO PRINCIPIOS ACTIVOS ENCAPSULADOS NA PRESENCA DE UM CLORIDRATO EM LIPOSOMAS MULTIVESICULARES | ⤷ Sign Up |
European Patent Office | 0839027 | ⤷ Sign Up | |
Japan | 2010043104 | EPIDURAL ADMINISTRATION OF THERAPEUTIC COMPOUNDS WITH SUSTAINED RATE OF RELEASE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |